Velsipity (etrasimod) — Point32Health

Initial criteria

• Documented diagnosis of ulcerative colitis
• Patient age ≥ 18 years
• Prescribed by or in consultation with a gastroenterologist
• Documentation of ONE of the following: (a) Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication required if only one available): Interleukin Antagonists (Omvoh, Skyrizi, Tremfya, Yesintek); Janus Kinase Inhibitors (Rinvoq, Xeljanz); Sphingosine 1-phosphate receptor modulator (Zeposia); Tumor Necrosis Factors (Humira, Simponi) OR (b) Contraindication to all of the following medications: Omvoh, Skyrizi, Tremfya, Yesintek, Rinvoq, Xeljanz, Zeposia, Humira, Simponi